Skip to main content
. 2015 Aug 31;4:9. doi: 10.5772/61320

Table 4.

Ratio between cfHER-2 DNA and cfB2M DNA prior to metastases detection

Ratio HER-2/B2M Ratio p-value p-value
Tissue HER-2-positive patients (N=15) Range 0.92–6.77 0.34 0.0001
Mean 2.26
Median 1.524
Tissue HER-2-negative patients (N=10) Range 0.98–2.23 1.0 0.001
Mean 1.55
Median 1.520
Healthy controls (N=47) Range 0.08–1.59 1.0
Mean 1.23
Median 1.25